For example, in colorectal and breast cancers, p16INK4a exhibited strong nuclear/cytoplasmic positivity in primary or metastatic carcinomas, whereas negativity or low nuclear expression was observed in normal mucosa and benign fibroadenoma [23,24]. This evidence concerns the gene CDKN2A and breast carcinoma.